TOCQX
Price
$48.03
Change
+$0.63 (+1.33%)
Updated
Jun 6 closing price
Net Assets
467.53M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

TOCQX vs VITSX

Header iconTOCQX vs VITSX Comparison
Open Charts TOCQX vs VITSXBanner chart's image
Tocqueville
Price$48.03
Change+$0.63 (+1.33%)
VolumeN/A
Net Assets467.53M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
TOCQX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TOCQX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TOCQX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. TOCQX (468M). VITSX pays higher dividends than TOCQX: VITSX (1.29) vs TOCQX (0.23). TOCQX was incepted earlier than VITSX: TOCQX (38 years) vs VITSX (28 years). TOCQX (1.35) is less costly to investors than VITSX (0.03). TOCQX is a more actively managed with annual turnover of: 18.00 vs. VITSX (2.00). TOCQX has a lower initial minimum investment than VITSX: TOCQX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. TOCQX (0.43). VITSX return over 5 years is better than : 80.96 vs. TOCQX (36.78).
TOCQXVITSXTOCQX / VITSX
Total Expense Ratio1.200.034,000%
Annual Report Gross Expense Ratio1.350.034,500%
Fund Existence38 years28 years-
Gain YTD1.4120.833169%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets468M1.82T0%
Annual Yield % from dividends0.231.2918%
Returns for 1 year0.4310.974%
Returns for 3 years11.7140.3529%
Returns for 5 years36.7880.9645%
Returns for 10 years48.29180.4927%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.